Nemalife Inc.
Lubbock, TX
- UEI
- JPKVJPK1ZYF2
- CAGE
- 73NV1
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 3911 4th St rm 140, Lubbock, TX 79430, USA
- Website
- nemalifeinc.com
- Founded
- 2018
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 87 Engineering & Management Services
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
About Nemalife Inc.
Nemalife Inc. is a for-profit corporate entity registered in SAM.gov since 2014, specializing in biotechnology research and high-throughput screening technologies using the nematode Caenorhabditis elegans as a model organism. The company has developed a proprietary screening platform called the Infinity Screening System 2.0 (ISS 2.0), which leverages advanced microfluidic technologies and artificial intelligence to conduct rapid, cost-effective biological research and drug discovery. Their core technological innovation involves using C. elegans as a sophisticated biological screening tool that allows for efficient, high-volume testing of compounds and potential therapeutics across various health domains.
The company has received multiple federal grants from civilian agencies, predominantly focusing on developing AI-assisted screening platforms for identifying potential therapeutics and understanding biological mechanisms across several critical health areas. Specific research domains have included alcohol use disorders, sarcopenia, cocaine addiction, Alzheimer's disease, and microbiome health, with grants awarded by agencies such as the National Institute on Aging, National Institute on Alcohol Abuse and Alcoholism, National Institute on Drug Abuse, National Center for Complementary and Integrative Health, and the National Institute of Environmental Health Sciences. These grants, ranging from approximately $295,000 to over $1 million, have supported projects developing high-throughput screening technologies that use C. elegans to rapidly test and characterize potential therapeutic compounds, assess chronic toxicity, and explore mechanisms of various health conditions. The research consistently emphasizes creating scalable, AI-powered screening methodologies that can accelerate drug discovery and provide insights into complex biological processes with potential translational applications for human health.
Quick answers
What is Nemalife Inc.'s UEI?
Nemalife Inc.'s Unique Entity ID (UEI) in SAM.gov is JPKVJPK1ZYF2.
What is Nemalife Inc.'s CAGE code?
Nemalife Inc.'s CAGE code is 73NV1.
What is Nemalife Inc.'s primary NAICS code?
Nemalife Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
Where is Nemalife Inc. located?
Nemalife Inc.'s physical address in SAM.gov is 3911 4th St rm 140, Lubbock, TX 79430, USA.
Is Nemalife Inc. registered in SAM.gov?
Yes. Nemalife Inc.'s SAM.gov registration is active through December 1, 2026.
What is Nemalife Inc.'s most recent federal award?
Nemalife Inc.'s most recent federal grant award is Development of a high throughput in vivo screening platform for identifying novel pro-and postbiotic bacterial strains -… (R43AT012449), from National Center for Complementary and Integrative Health, on September 17, 2024.
On GovTribe
See Nemalife Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors